Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Su

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
F1000Research|April 15, 2017
Studying human immunodeficiencies in humans: advances in fundamental concepts and therapeutic interventionsHelen Su
Immunity|August 17, 2004
Another fork in the road: Foxo3a regulates NF-kappaB activationHelen Su, Nicolas Bidere, Michael Lenardo
ILAR Journal|January 4, 2008
Anesthesia and other considerations for in vivo imaging of small animalsIsabel J Hildebrandt, Helen Su, Wolfgang A Weber
The Journal of Chiropractic Education|August 3, 2017
A cross-sectional study of chiropractic students' research readiness using the Academic Self-Concept Analysis ScaleStephney Whillier, Kent Au, Louie Feng, et al.
Molecular Imaging and Biology|June 15, 2004
Quantitation of cell number by a positron emission tomography reporter gene strategyHelen Su, Ashley Forbes, Sanjiv S Gambhir, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
Monitoring the antitumor response of naive and memory CD8 T cells in RAG1-/- mice by positron-emission tomographyHelen Su, Daisy S Chang, Sanjiv S Gambhir, et al.
Clinical Immunology (Orlando, Fla.)|May 24, 2003
The tetraspan protein EMP2 increases surface expression of class I major histocompatibility complex proteins and susceptibility to CTL-mediated cell deathMadhuri Wadehra, Helen Su, Lynn K Gordon, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2007
Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imagingDerek W Bartlett, Helen Su, Isabel J Hildebrandt, et al.
Blood|February 20, 2014
XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virusFeng-Yen Li, Benjamin Chaigne-Delalande, Helen Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Changes in tumor metabolism as readout for Mammalian target of rapamycin kinase inhibition by rapamycin in glioblastomaLiu Hua Wei, Helen Su, Isabel J Hildebrandt, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
F1000Research|April 15, 2017
Studying human immunodeficiencies in humans: advances in fundamental concepts and therapeutic interventionsHelen Su
Immunity|August 17, 2004
Another fork in the road: Foxo3a regulates NF-kappaB activationHelen Su, Nicolas Bidere, Michael Lenardo
ILAR Journal|January 4, 2008
Anesthesia and other considerations for in vivo imaging of small animalsIsabel J Hildebrandt, Helen Su, Wolfgang A Weber
The Journal of Chiropractic Education|August 3, 2017
A cross-sectional study of chiropractic students' research readiness using the Academic Self-Concept Analysis ScaleStephney Whillier, Kent Au, Louie Feng, et al.
Molecular Imaging and Biology|June 15, 2004
Quantitation of cell number by a positron emission tomography reporter gene strategyHelen Su, Ashley Forbes, Sanjiv S Gambhir, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
Monitoring the antitumor response of naive and memory CD8 T cells in RAG1-/- mice by positron-emission tomographyHelen Su, Daisy S Chang, Sanjiv S Gambhir, et al.
Clinical Immunology (Orlando, Fla.)|May 24, 2003
The tetraspan protein EMP2 increases surface expression of class I major histocompatibility complex proteins and susceptibility to CTL-mediated cell deathMadhuri Wadehra, Helen Su, Lynn K Gordon, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2007
Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imagingDerek W Bartlett, Helen Su, Isabel J Hildebrandt, et al.
Blood|February 20, 2014
XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virusFeng-Yen Li, Benjamin Chaigne-Delalande, Helen Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Changes in tumor metabolism as readout for Mammalian target of rapamycin kinase inhibition by rapamycin in glioblastomaLiu Hua Wei, Helen Su, Isabel J Hildebrandt, et al.
Pageof 5